Untitled - The Canadian Association of Gastroenterology

Le foie 745
Section 15 Ascite et péritonite bactérienne spontanée
Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory
ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996; 23:164-176.
Moore KP, Wong F, Gines P, et al. The management of ascites: report on the consensus
conference of the International Ascites Club. Hepatology 2003; 38:258-266.
Rimola A, García-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous
bacterial peritonitis: a consensus document. J Hepatol 2000; 32:142-153.
Toledo C, Salmeron JM, Rimola A, et al. Spontaneous bacterial peritonitis in cirrhosis:
predictive factors of infection resolution and survival in patients treated with
cefotaxime. Hepatology 1993; 17:251-257.
Yeung E, Wong FS. The management of cirrhotic ascites. Med Gen Med 2002; 4(4):8.
Section 16 Encéphalopathie hépatique
Butterworth RF. Pathogenesis of hepatic encephalopath: new insights from neuroimaging
and molecular studies. J Hepatol 2003; 39(2):278-285.
Ferenci P, Muller CH. Hepatic encephalopathy: treatment. In: Burroughs A, Feagan B,
McDonald JWB (eds.). Evidence based gastroenterology. London: BMJ, 1999:443.
Lizardi-Cervera J, Almeda P, Guevara L, Uribe M. Hepatic encephalopathy: a review.
Ann Hepatol 2003; 2(3):122-130.
Vaquero J, Chung C, Cahill ME, Blei AT. Pathogenesis of hepatic encephalopathy in
acute liver failure. Semin Liver Dis 2003; 23(3): 259-269.
Section 17 Syndrome hépato-rénal
Angeli P, Volpin R, Gerunda G, et al. Reversal of type 1 hepatorenal syndrome with
the administration of midodrine and octreotide. Hepatology 1999; 29:1690-1697.
Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory
ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996; 23:164-176.
Forni LG, Hilton PJ. Continuous hemofiltration in the treatment of acute renal failure.
N Engl J Med 1997; 336:1303-1309.
Gines A, Escorsell A, Gines P, et al. Incidence, predictive factors, and prognosis of
hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993; 105:229-236.
Guevera M, Gines P, Bandi C, et al. Transjugular intrahepatic portosystemic shunt in
hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology
1998; 28:416-422.
Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral
arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and
water retention in cirrhosis. Hepatology 1988; 8:1151-1157.
Wong F, Blendis L. New challenge of hepatorenal syndrome: prevention and treatment.
Hepatology 2001; 34:1242-1251.
Section 18 Greffe de foie
Cattral MS, Molinari M, Vollmer CM Jr, et al. Living-donor right hepatectomy with or
without inclusion of middle hepatic vein: comparison of morbidity and outcome in
56 patients. Am J Transplant 2004; 4(5):751-757.
Freeman RB Jr, Wiesner RH, Roberts JP, McDiarmid S, Dykstra DM, Merion RM.
Improving liver allocation: MELD and PELD. Am J Transplant 2004; 4(Suppl. 9):
114-131.